IceCure Medical (ICCM) Competitors $0.88 +0.01 (+0.82%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$0.89 +0.01 (+0.59%) As of 08/22/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICCM vs. MGRM, CVRX, SI, KRMD, CV, INFU, INGN, PROF, ELMD, and PDEXShould you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Monogram Orthopaedics (MGRM), CVRx (CVRX), Shoulder Innovations (SI), KORU Medical Systems (KRMD), CapsoVision (CV), InfuSystem (INFU), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. IceCure Medical vs. Its Competitors Monogram Orthopaedics CVRx Shoulder Innovations KORU Medical Systems CapsoVision InfuSystem Inogen Profound Medical Electromed Pro-Dex IceCure Medical (NASDAQ:ICCM) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership. Is ICCM or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to IceCure Medical's net margin of -317.62%. Monogram Orthopaedics' return on equity of -126.82% beat IceCure Medical's return on equity.Company Net Margins Return on Equity Return on Assets IceCure Medical-317.62% -136.96% -71.46% Monogram Orthopaedics N/A -126.82%-96.87% Do insiders & institutionals have more ownership in ICCM or MGRM? 0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to ICCM or MGRM? In the previous week, Monogram Orthopaedics had 3 more articles in the media than IceCure Medical. MarketBeat recorded 12 mentions for Monogram Orthopaedics and 9 mentions for IceCure Medical. Monogram Orthopaedics' average media sentiment score of 0.18 beat IceCure Medical's score of -0.22 indicating that Monogram Orthopaedics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IceCure Medical 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Monogram Orthopaedics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, ICCM or MGRM? IceCure Medical has a beta of 0.32, meaning that its share price is 68% less volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Which has preferable valuation & earnings, ICCM or MGRM? IceCure Medical has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIceCure Medical$3.29M15.75-$15.32M-$0.16-5.52Monogram Orthopaedics$370K598.47-$16.33M-$0.50-10.90 Do analysts prefer ICCM or MGRM? IceCure Medical currently has a consensus price target of $2.39, suggesting a potential upside of 170.16%. Monogram Orthopaedics has a consensus price target of $5.40, suggesting a potential downside of 0.92%. Given IceCure Medical's higher probable upside, equities research analysts plainly believe IceCure Medical is more favorable than Monogram Orthopaedics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryIceCure Medical and Monogram Orthopaedics tied by winning 8 of the 16 factors compared between the two stocks. Get IceCure Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICCM vs. The Competition Export to ExcelMetricIceCure MedicalMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.40M$7.70B$5.76B$9.58BDividend YieldN/A2.71%4.41%4.10%P/E Ratio-5.5278.4731.1026.05Price / Sales15.7549.17433.22103.03Price / CashN/A24.6737.7358.48Price / Book17.6624.799.536.61Net Income-$15.32M$243.33M$3.26B$265.56M7 Day Performance-1.73%1.08%2.10%1.97%1 Month Performance-8.99%-0.65%2.81%-0.36%1 Year Performance21.48%10.34%30.56%19.03% IceCure Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICCMIceCure Medical1.9146 of 5 stars$0.88+0.8%$2.39+170.2%+27.1%$51.40M$3.29M-5.5260MGRMMonogram Orthopaedics1.7916 of 5 stars$5.38-0.4%$5.40+0.4%+60.3%$192.71M$370K-11.9628Trending NewsEarnings ReportShort Interest ↓Analyst RevisionCVRXCVRx2.5882 of 5 stars$7.51+3.7%$14.00+86.4%-6.5%$189.34M$51.29M-3.58160SIShoulder InnovationsN/A$12.08-2.7%N/AN/A$188.99MN/A-0.4061Positive NewsKRMDKORU Medical Systems1.0869 of 5 stars$4.04+2.0%$4.63+14.5%+98.2%$183.09M$33.65M-44.8980CVCapsoVisionN/A$4.11+4.6%$5.50+33.8%N/A$182.13MN/A0.0090INFUInfuSystem3.6377 of 5 stars$8.60-2.6%$12.50+45.3%N/A$175.66M$139.89M143.36410Positive NewsHigh Trading VolumeINGNInogen4.3484 of 5 stars$7.04+8.6%$11.00+56.3%-36.6%$174.23M$335.70M-6.641,030PROFProfound Medical1.759 of 5 stars$5.63+1.6%$11.00+95.4%-49.1%$166.49M$10.68M-4.61150ELMDElectromed1.9955 of 5 stars$19.15+2.7%$33.50+74.9%+31.4%$160.59M$61.44M25.53160Positive NewsPDEXPro-Dex1.6762 of 5 stars$38.41-19.6%$56.00+45.8%+122.4%$155.71M$53.84M13.72140High Trading Volume Related Companies and Tools Related Companies MGRM Alternatives CVRX Alternatives SI Alternatives KRMD Alternatives CV Alternatives INFU Alternatives INGN Alternatives PROF Alternatives ELMD Alternatives PDEX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICCM) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share IceCure Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access